SYNEOS HEALTH
LIVE

Serial Number

87717521

Owner

INC Research, LLC

Attorney

Michael A. Geller

First Use Date

Jan 4, 2018

Filing Date

Dec 12, 2017

Add to watchlist:

No watchlists yet
View on USPTO

SYNEOS HEALTH Trademark

Serial Number: 87717521 • Registration: 5814321

SYNEOS HEALTH is a trademark filed by INC Research, LLC on December 12, 2017. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

INC Research, LLC (11 trademarks)

Suite 600
Raleigh, NC 276041547

Entity Type: 16

SYNEOS HEALTH, LLC (17 trademarks)

1030 SYNC STREET
MORRISVILLE, NC 27560

Entity Type: 16

Trademark Details

Filing Date

December 12, 2017

Registration Date

July 23, 2019

First Use Anywhere

January 4, 2018

First Use in Commerce

January 4, 2018

Published for Opposition

January 8, 2019

Goods & Services

Education in the field of pharmaceutical sales, namely, providing webinars, providing live workshops, providing on-line non-downloadable videos, providing on-line non-downloadable publications in the nature of articles and white papers, and providing podcasts; training services in the field of pharmaceutical sales; providing on-line non-downloadable newsletters and bulletins in the pharmaceutical, biotechnology and life sciences fields; educational services in the field of clinical trials, namely, providing on-line non-downloadable videos, webinars, live workshops, providing online non-downloadable publications in the nature of articles and white papers, and providing podcasts

Medical, scientific and data analysis research services for others, namely, conducting and analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; pharmaceutical drug development services, namely, developing clinical trial methodologies; consulting services in the area of pharmaceutical clinical testing; extended clinical research services for others, namely, computerized data management of clinical trials, biostatistical analysis, environmental consultancy, preclinical research and development evaluation, repairing flawed clinical trials and dossiers, strategic clinical research portfolio management, and biosurveillance monitoring; providing life science and scientific research information to physicians and other health care professionals, patients, and medical, pharmaceutical and biotechnology companies; providing regulatory compliant technical writing services in the field of medical research and clinical studies; consulting services in the field of contract clinical research and contract product development; Internet development, design and consulting services for others, namely, creating websites featuring blogs about medical and pharmaceutical information related to chronic illnesses and disease, creating an online community for patients and caregivers to communicate about healthcare, and design and development of interactive software for use in the communication and dissemination of medical and pharmaceutical information

Strategic business consulting, marketing and advertising, public relations communications strategy, information and data collection for business purposes, and business data analytics, namely, analyzing business data to understand and evaluate business performance, all of the aforementioned in the pharmaceutical, biotechnology and life sciences fields; sales promotion services; market analysis and research services; personnel recruitment and placement; recruitment services, namely, advertising clinical trials, recruiting patients, and placing patients for participation in clinical trials for testing of pharmaceuticals and devices; consulting in sales techniques and sales programs; sales volume tracking for others, all in the pharmaceutical, biotechnology and life sciences fields; business consulting in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, pharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; assisting pharmaceutical and biotechnology companies with applications for new drugs with governmental regulatory bodies; promoting the exchange of health information to promote patient adherence

Providing medical information to physicians, other health care professionals and for medical patients; providing health information regarding the medications and health care products of others, namely, product discontinuations, new formulations, bottle changes, and seasonal information through e-mail alerts and push notifications

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Nov 10, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Nov 10, 2025 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 10, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Jul 21, 2025 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 23, 2024 REM1
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 4, 2023 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Mar 15, 2023 ASCK
REGISTERED-PRINCIPAL REGISTER
Jul 23, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 15, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 14, 2019 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 18, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 18, 2019 AITU
USE AMENDMENT FILED
May 6, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
May 6, 2019 EISU
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 24, 2019 ASGN
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 2, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 2, 2019 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 5, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 8, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jan 8, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 19, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 15, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 5, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 4, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 4, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 5, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jul 5, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jul 5, 2018 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 14, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 14, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 14, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 30, 2018 GNRN
NON-FINAL ACTION E-MAILED
Mar 30, 2018 GNRT
NON-FINAL ACTION WRITTEN
Mar 30, 2018 CNRT
ASSIGNED TO EXAMINER
Mar 22, 2018 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 22, 2017 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 21, 2017 NWOS
NEW APPLICATION ENTERED
Dec 15, 2017 NWAP